Delivery Order SPE2DR25D3103-SPE2DR26F9J52
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $12,426.16 and a completion date of November 18, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $37,519.00. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to conclude on November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication in 3 mL vials, with a contract ceiling value of $17,734.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters. The...
- The Defense Logistics Agency awarded a $5,507.39 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $11,016.06 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with performance scheduled through November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,891.23 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical product requisition under the agency's medical supply procurement operations. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $88,926.94 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 14, 2025. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $5,417.78. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a specific purchase under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,883.86 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials on May 27, 2025, with an ultimate completion date of May 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $8,236.17 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion expected by October 28, 2025. This non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J52Delivery Order
The Defense Logistics Agency awarded a $11,867.82 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials on November 25, 2025, with a completion date of November 26, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued against AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, extending through December 2026. The parent contract functions as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. Ozempic, a diabetes medication, falls within the contract's scope of specialty pharmaceutical products supporting Defense Health Agency and other government healthcare systems. AmerisourceBergen's substantial federal contract portfolio demonstrates its established capability to fulfill complex medical supply requirements through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 11/24/25 |